This patent covers the use of valproic acid for inducing differentiation of neurons from neural stem cells.
This patent seems to be restricted in the claims to the in vitro differentiation of neurons. What is interesting is whether the concentrations claimed in the patent are actually achievable in vivo.
Since valproic acid is clinically used as an anticonvulsant, it is interesting to speculate whether its activities are related to augmentation of stem cells in vivo.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.